Find uplifting stories about heroes, innovations, and solutions
5007 results for "pancreatic cancer detection"
A new AI system spotted pancreatic cancer on routine scans more than a year before human radiologists could see it, offering hope for one of the deadliest cancers. The breakthrough could transform early detection for a disease that kills 92% of patients within five years.
A new AI tool from Mayo Clinic spots pancreatic cancer on routine CT scans up to three years before doctors would normally diagnose it, nearly doubling the detection rate of expert radiologists. The breakthrough could transform outcomes for a cancer that kills most patients simply because it's found too late.
A new AI system from Mayo Clinic can spot pancreatic cancer on routine CT scans up to three years before doctors typically diagnose it, when the disease is still treatable. The breakthrough could transform survival rates for one of the deadliest cancers.
Scientists at Indiana University have discovered biological warning signals that could catch pancreatic cancer before it becomes deadly. For a disease where 80% of patients are diagnosed too late, these breakthroughs offer real hope for saving lives.
Scientists developed a four-biomarker blood test that catches pancreatic cancer earlier than ever before, potentially saving thousands of lives. The breakthrough could help doctors identify the deadly disease when it's still treatable.
A groundbreaking AI model can detect pancreatic cancer on CT scans up to three years before tumors become visible, offering hope for one of the deadliest cancers. The Mayo Clinic tool is three times better than human radiologists at catching early warning signs.
Scientists have developed a four-marker blood test that detects pancreatic cancer in its earliest stages with nearly 88% accuracy. This breakthrough could transform survival rates for one of the deadliest cancers, which currently kills 9 out of 10 patients within five years.
Scientists at Yale discovered that obesity triggers pancreatic cells to produce a hormone that drives cancer development, opening the door to early detection through simple blood tests. The breakthrough challenges decades of scientific assumptions about how obesity leads to one of the deadliest cancers.
A new pill targeting the KRAS mutation doubles survival time in pancreatic cancer patients, marking the biggest treatment breakthrough ever for one of the world's deadliest cancers. After 25 years of research and $17 million in funding, scientists are finally seeing progress on multiple fronts at once.
Scientists in Spain eliminated pancreatic tumors in mice using a triple-drug therapy, with no cancer returning over 200 days. The breakthrough targets the deadliest form of pancreatic cancer and could reshape treatment if human trials succeed.
A daily pill called daraxonrasib helped control cancer in 90% of pancreatic cancer patients during early trials, offering new hope for a disease that has had few effective treatments. The drug targets genetic mutations found in over 90% of pancreatic cancers.
A breakthrough drug called daraxonrasib doubled survival time for pancreatic cancer patients compared to chemotherapy, offering new hope for one of the deadliest cancers. The treatment targets the genetic mutation behind 90% of pancreatic cancers and causes far fewer severe side effects.
A handheld device the size of a deck of cards can detect lung cancer from a one-minute breath test, using graphene sensors that identify disease markers. The technology could catch cancer years earlier, when treatment is seven times less expensive and survival rates are highest.
A new AI system called REDMOD can detect pancreatic cancer up to three years before doctors can see it on scans, catching the deadliest form of the disease when treatment actually works. In testing, it outperformed expert radiologists by nearly three times for early detection.
A breakthrough drug targeting previously "undruggable" KRAS mutations has approximately doubled survival time for metastatic pancreatic cancer patients compared to chemotherapy. The development marks a historic shift for a disease that affects over 90% of pancreatic cancer cases. --- ##
A San Antonio woman's unusual abdominal pain led doctors to discover pancreatic cancer months before typical symptoms appear, giving her a fighting chance most patients never get. Her story shows why listening to your body matters.
A breakthrough drug for pancreatic cancer has stunned researchers by controlling disease in 90% of patients who had already tried chemotherapy. The daily pill targets gene mutations found in nearly all pancreatic cancers, offering hope where treatment options have been scarce.
Scientists at Oregon Health & Science University discovered that stress nerves help pancreatic tumors grow, opening doors to potential new treatments. The breakthrough could transform how we fight one of the deadliest cancers.
For the first time in three decades, patients with inoperable pancreatic cancer have a new treatment option. The FDA just approved Optune Pax, a wearable device you use at home that uses electric fields to kill cancer cells.
Scientists in Ireland have created the first complete "playbook" of pancreatic cancer, revealing why it's been so deadly and where new treatments could finally work. Their breakthrough approach targets multiple weak points at once, offering fresh hope for a disease that has resisted progress for decades.
Showing 20 of 5007